Literature DB >> 15883006

Inhibition of beta-catenin-mediated transactivation by flavanone in AGS gastric cancer cells.

Chi Hoon Park1, Eun Ryeong Hahm, Ju Hyung Lee, Kyung Chae Jung, Chul Hak Yang.   

Abstract

Recently, data which prove that Wnt pathway activation may be an early event in multistep carcinogenesis in the stomach have been accumulating. We examined the effect of flavanone against beta-catenin/Tcf signaling in AGS gastric cancer cells. Reporter gene assay showed that flavanone inhibited beta-catenin/Tcf signaling efficiently. In addition, the inhibition of beta-catenin/Tcf signaling by flavanone in HEK293 cells transiently transfected with constitutively mutant beta-catenin gene, whose product is not phosphorylated by GSK3beta, indicates that its inhibitory mechanism was related to beta-catenin itself or downstream components. To investigate the precise inhibitory mechanism, we performed immunofluorescence, Western blot, and EMSA. As a result, our data revealed that there is no change of beta-catenin distribution and of nuclear beta-catenin levels through flavanone. In addition, the binding of Tcf complexes to DNA is not influenced by flavanone. The beta-catenin/Tcf transcriptional target gene cyclinD1 was downregulated by flavanone. These data suggest that flavanone inhibits the transcription of beta-catenin/Tcf responsive genes, by modulating Tcf activity without disrupting beta-catenin/Tcf complex formation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15883006     DOI: 10.1016/j.bbrc.2005.03.242

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

Review 1.  Role of the Wnt/β-catenin pathway in gastric cancer: An in-depth literature review.

Authors:  Miguel Angel Chiurillo
Journal:  World J Exp Med       Date:  2015-05-20

Review 2.  Sustained proliferation in cancer: Mechanisms and novel therapeutic targets.

Authors:  Mark A Feitelson; Alla Arzumanyan; Rob J Kulathinal; Stacy W Blain; Randall F Holcombe; Jamal Mahajna; Maria Marino; Maria L Martinez-Chantar; Roman Nawroth; Isidro Sanchez-Garcia; Dipali Sharma; Neeraj K Saxena; Neetu Singh; Panagiotis J Vlachostergios; Shanchun Guo; Kanya Honoki; Hiromasa Fujii; Alexandros G Georgakilas; Alan Bilsland; Amedeo Amedei; Elena Niccolai; Amr Amin; S Salman Ashraf; Chandra S Boosani; Gunjan Guha; Maria Rosa Ciriolo; Katia Aquilano; Sophie Chen; Sulma I Mohammed; Asfar S Azmi; Dipita Bhakta; Dorota Halicka; W Nicol Keith; Somaira Nowsheen
Journal:  Semin Cancer Biol       Date:  2015-04-17       Impact factor: 15.707

3.  Effects of genistein and daidzein on cell proliferation kinetics in HT29 colon cancer cells: the expression of CTNNBIP1 (β-catenin), APC (adenomatous polyposis coli) and BIRC5 (survivin).

Authors:  Sandra Regina Lepri; Leonardo Campos Zanelatto; Patrícia Benites Gonçalves da Silva; Daniele Sartori; Lucia Regina Ribeiro; Mario Sergio Mantovani
Journal:  Hum Cell       Date:  2014-01-04       Impact factor: 4.174

Review 4.  Modulation of Wnt/β-catenin signaling pathway by bioactive food components.

Authors:  Rohinton S Tarapore; Imtiaz A Siddiqui; Hasan Mukhtar
Journal:  Carcinogenesis       Date:  2011-12-22       Impact factor: 4.944

Review 5.  Naturally occurring compounds acting as potent anti-metastatic agents and their suppressing effects on Hedgehog and WNT/β-catenin signalling pathways.

Authors:  L Farahmand; B Darvishi; K Majidzadeh-A; A Madjid Ansari
Journal:  Cell Prolif       Date:  2016-09-27       Impact factor: 6.831

6.  Amide derivatives of ethacrynic acid: synthesis and evaluation as antagonists of Wnt/beta-catenin signaling and CLL cell survival.

Authors:  Guangyi Jin; Desheng Lu; Shiyin Yao; Christina C N Wu; Jerry X Liu; Dennis A Carson; Howard B Cottam
Journal:  Bioorg Med Chem Lett       Date:  2008-12-24       Impact factor: 2.823

7.  Structure-activity relationship studies of small-molecule inhibitors of Wnt response.

Authors:  Jianming Lu; Zhiqiang Ma; Jen-Chieh Hsieh; Chih-Wei Fan; Baozhi Chen; Jamie C Longgood; Noelle S Williams; James F Amatruda; Lawrence Lum; Chuo Chen
Journal:  Bioorg Med Chem Lett       Date:  2009-04-18       Impact factor: 2.823

Review 8.  The Wnt-dependent signaling pathways as target in oncology drug discovery.

Authors:  Nico Janssens; Michel Janicot; Tim Perera
Journal:  Invest New Drugs       Date:  2006-07       Impact factor: 3.850

9.  18β-glycyrrhetinic acid suppresses gastric cancer by activation of miR-149-3p-Wnt-1 signaling.

Authors:  Donghui Cao; Zhifang Jia; Lili You; Yanhua Wu; Zhen Hou; Yueer Suo; Houjun Zhang; Simin Wen; Tetsuya Tsukamoto; Masanobu Oshima; Jing Jiang; Xueyuan Cao
Journal:  Oncotarget       Date:  2016-11-01

Review 10.  Polyphenol Compound as a Transcription Factor Inhibitor.

Authors:  Seyeon Park
Journal:  Nutrients       Date:  2015-10-30       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.